The Blood and Marrow Transplant Program in collaboration with Robert Wood Johnson University Hospital, an RWJBarnabas Health facility, has been performing autologous and allogeneic stem cell transplants since 1995 and is the only such program in New Jersey that is part of an NCI-designated Comprehensive Cancer Center. Transplants are performed for patients with a variety of illnesses, including acute and chronic leukemias, myelodysplasia, various types of lymphoma, Hodgkin's disease, multiple myeloma, amyloidosis and related diseases. Our skilled team of hematologist/oncologists, advanced practice nurses, bone marrow transplant coordinators, oncology nurse navigators, and social workers come together to make sure their patients have the best care, tailored to individual needs.
In addition to participating in national and international research studies with other transplant centers, there are unique research programs at Rutgers Cancer Institute focusing on novel ways to: prevent graft-versus-host disease; improve umbilical cord blood transplants; and develop novel cellular therapies with less toxicity than standard transplants.
The Program is accredited by the National Marrow Donor Program and FACT and has been rated as an “Excellent Program” by the American College of Surgeons.
Roger Strair, MD, PhD, Chief, Blood Disorders
Dennis Cooper, MD, Chief, Blood and Marrow Transplantation
Andrew M. Evens, DO, MSc, FACP, Associate Director for Clinical Services and Director, Lymphoma Program
Hematologist/Oncologists
Roger Strair, MD, PhD, Chief, Blood DisordersDennis Cooper, MD, Chief, Blood and Marrow TransplantationAndrew M. Evens, DO, MSc, FACP, Associate Director for Clinical Services and Director, Lymphoma Program
Kevin David, MD
Anu Doraiswamy, MD
Vimal Patel, MD
Dale Schaar, MD, PhD
Radiation Oncologist
Rahul R. Parikh, MD, Medical Director, Laurie Proton Therapy Center
